A leading private equity player

The power of and

Companies must face multiple challenges to innovate, grow and adapt to a rapidly changing environment. It has been Andera Partners’ mission for over 20 years to help companies and their management achieve strong and sustainable growth. Our conviction, at the heart of our commitment, our partnership and our way to work with entrepreneurs, is that to grow and develop, it is essential to have the right partners and enjoy working together. The Power of And thus becomes Andera Partners’ signature that relays our conviction.

Our commitments Our investments

2.5 billion under management

250 companies supported for 20 years

70 professionals

Our Activities

Andera Partners is an asset management firm specialising in Private Equity. We draw on our expertise in various areas to provide a range of well-defined investment strategies. Our goal is to provide bespoke solutions to meet the challenges faced by leaders and their development models.

Our activities

Our Latest News

Below you will find all the latest news on Andera Partners, its teams and its investments.

21.10.2020 - Andera Partners - Press releases

The Power of And

Combined Shape

12.10.2020 - BioDiscovery - Press releases

Medlumics lands a 14M€ new financing round

Combined Shape

28.08.2020 - BioDiscovery - Press releases

Reviral raises $44 million in Series C financing

Combined Shape

06.08.2020 - BioDiscovery - Press releases

T-knife completes €66m Series A financing

Combined Shape

23.07.2020 - BioDiscovery - Press reviews

COVID-19: assessing nangibotide in mechanically ventilated patients with COVID-19

Combined Shape

29.06.2020 - Actomezz - Press releases

ActoMezz IV: a single closing at more than €500 million

Combined Shape

11.06.2020 - BioDiscovery - Press releases

BioDiscovery sells Corvidia to Novo Nordisk

Combined Shape

06.05.2020 - BioDiscovery - Press releases

Appointment of Michael H. Carrel as chairman of the Axonics board of directors.

Combined Shape

06.05.2020 - BioDiscovery - Press releases

 Axonics Modulation Technologies reports financial results for the 1st quarter 2020 and provides an…

Combined Shape

06.05.2020 - Andera Partners - Press releases

Andera Partners welcomes Constance Jay and strengthens its Investor Relations

Combined Shape

02.04.2020 - BioDiscovery - Press releases

Dynacure Announces €50M ($55M) Series C Financing

Combined Shape

01.04.2020 - BioDiscovery - Press releases

AM-Pharma Increases Funding to €163m for Phase-III Trial of recAP in SA-AKI

Combined Shape

05.03.2020 - Andera Partners - Publications

Newsletter – 03/2020

Combined Shape

28.02.2020 - BioDiscovery - Press releases

Allecra Therapeutics announces positive top-Line results for phase 3 ALLIUM clinical trial of EXBLIF…

Combined Shape

27.02.2020 - Andera Partners - Press releases

2019: a new record year for Andera

Combined Shape
Our Latest News